Emily J Cicali

Emily J Cicali, Pharm.D.

Clinical Assistant Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-7919
Business Email: emily.cicali@cop.ufl.edu

About Emily J Cicali

Emily Cicali, Pharm.D., received her Doctor of Pharmacy degree from Philadelphia College of Pharmacy, University of the Sciences in 2015. She then completed a Pharmacy Practice Residency at Tabula Rasa HealthCare in Geriatric Personalized Medicine. After her residency, she was hired to work Tabula Rasa HealthCare at as a Research Pharmacist, as well as adjunct faculty at the Philadelphia College of Pharmacy, focusing on clinical pharmacokinetics and pharmacogenomics implementation. In 2017 she decided to fully transition to academia, which led to her completion of a fellowship in pharmacogenomics at the University of Florida. Cicali is now a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research. Her clinical practice is within the UF Health Personalized Medicine Program and her research interests include clinical implementation of pharmacogenomics as well as further understanding the role of phenoconversion for optimal medication safety.

Board Certifications

  • Board-certified pharmacotherapy specialist (BCPS)
    Board of Pharmacy Specialties

Research Profile

Research Interests: Clinical implementation of pharmacogenomics, pharmacokinetic changes caused by CYP-inhibitors (phenoconversion, survey research to patients and prescribers to determine attitudes and acceptability of pharmacogenomics

Open Researcher and Contributor ID (ORCID)

0000-0002-3595-9321

Publications

2021
Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic.
Clinical and translational science. 14(2):589-598 [DOI] 10.1111/cts.12914. [PMID] 33166056.
2021
Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease
The Pharmacogenomics Journal. 21(6):657-663 [DOI] 10.1038/s41397-021-00244-6. [PMID] 34075203.
2021
How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial.
Clinical pharmacology and therapeutics. 110(3):677-687 [DOI] 10.1002/cpt.2354. [PMID] 34231197.
2021
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
Genetics in medicine : official journal of the American College of Medical Genetics. [DOI] 10.1038/s41436-021-01269-9. [PMID] 34282303.
2021
The Complex Roadmap to Infectious Disease Innovation: The Intersection of Bugs, Drugs, and Special Populations.
Clinical pharmacology and therapeutics. 109(4):793-796 [DOI] 10.1002/cpt.2208. [PMID] 33769563.
2020
A Scoping Review of the Evidence Behind Cytochrome P450 2D6 Isoenzyme Inhibitor Classifications.
Clinical pharmacology and therapeutics. 108(1):116-125 [DOI] 10.1002/cpt.1768. [PMID] 31910286.
2020
How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial.
Clinical pharmacology and therapeutics. 108(3):557-565 [DOI] 10.1002/cpt.1912. [PMID] 32460360.
2020
Precision medication: An illustrative case series guiding the clinical application of multi-drug interactions and pharmacogenomics.
Clinical case reports. 8(2):305-312 [DOI] 10.1002/ccr3.2604. [PMID] 32128178.
2019
Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.
Genetics in medicine : official journal of the American College of Medical Genetics. 21(10):2264-2274 [DOI] 10.1038/s41436-019-0500-7. [PMID] 30926959.
2019
IGNITE network: Response of patients to genomic medicine interventions.
Molecular genetics & genomic medicine. 7(5) [DOI] 10.1002/mgg3.636. [PMID] 30895746.
2019
Novel Implementation of Genotype-Guided Proton Pump Inhibitor Medication Therapy in Children: A Pilot, Randomized, Multisite Pragmatic Trial.
Clinical and translational science. 12(2):172-179 [DOI] 10.1111/cts.12589. [PMID] 30341969.
2018
Implementation of a pharmacist-led pharmacogenomics serviceĀ for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
Journal of the American Pharmacists Association : JAPhA. 58(3):281-289.e1 [DOI] 10.1016/j.japh.2018.02.011. [PMID] 29602745.
2017
Implementation of a Standardized Medication Therapy Management Plus Approach within Primary Care.
Journal of the American Board of Family Medicine : JABFM. 30(6):701-714 [DOI] 10.3122/jabfm.2017.06.170145. [PMID] 29180545.
2017
Reducing Off-Label Antipsychotic Use in Older Community-Dwelling Adults With Dementia: A Narrative Review.
The Journal of the American Osteopathic Association. 117(7):441-450 [DOI] 10.7556/jaoa.2017.090. [PMID] 28662557.
2017
The Role of Hospital Pharmacists in the Adoption and Use of Pharmacogenomics and Precision Medicine
Personalized Medicine. 14(1):27-35

Grants

Sep 2021 ACTIVE
Warfarin Pharmacogenetics at UF Health
Role: Principal Investigator
Funding: UF HEALTH SHANDS HOSPITAL
Jul 2019 ACTIVE
Expansion of the Phamacogentics (PGx) Consultation Clinic to Family Medicine
Role: Principal Investigator
Funding: UF HEALTH SHANDS HOSPITAL

Education

Postdoctoral Fellowship in Pharmacogenomics
2017-2018 · University of Florida
PGY1 Pharmacy Residency: Geriatric Personalized Medicine & Targeted Therapeutics
2015-2016 · CareKinesis Inc.
Pharm.D.
2015 · Philadelphia College of Pharmacy
B.S.
2013 · Philadelphia College of Pharmacy

Teaching Profile

Courses Taught
2019,2021
PHA5012 App Personalized Med
2019,2021
PHA5166L Prof Skills Lab Vi
2021
PHA5132 Prin Drug Ther Indiv

Contact Details

Phones:
Business:
(352) 273-7919
Emails: